Extensively drug-resistant tuberculosis (XDR-TB) is curable with intensive and specialized care conclude two recent studies published in the New England Journal of Medicine (NEJM) and The Lancet. Researchers found that fully 60 percent of the patients enrolled in the studies with XDR-TB were successfully treated and cured.

In the small mountainous country of Lesotho, patients infected with multidrug-resistant tuberculosis (MDR-TB) faced almost certain death just one year ago. Today they and their families have reason to hope for a better prognosis. Last July, the first patients enrolled in Lesotho

Every since she was a child growing up in Haiti, Marie Myrléne St. Vil Marius has wanted to dedicate her life “to people who have nothing and are in need.”

The first scientific-practical training course "Treatment of Patients with MDR-TB" was held for doctors and TB specialists of the countries of the Commonwealth of Independent States (CIS) in Tomsk, Siberia this June.

PIH trains doctors across Russian in MDR-TB treatment.

PIH Lesotho starts model to treat MDR-TB and HIV/AIDS in Lesotho.

Since the beginning of 2007, PIH has ramped up its advocacy activities aimed at influencing policy and funding priorities at the national and global levels. PIH staff have testified in Congress, spoe press conferences and taken a leading role at meetings organized by the World Health Organization. Recent advocacy efforts have focused on increasing awareness and funding to address both the health worker crisis in Africa and the global spread of extensively drug-resistant tuberculosis (XDR-TB).

Dr. Joia Mukherjee discusses the urgency of treating the widespread MDR-TB epidemic.

Socios En Salud, long recognized as a leader for innovating community-based treatment for MDR-TB and for training other health professionals how to do it, has redoubled training activities, sending teams to Haiti and Africa and hosting nurses from Latin America.

With help from a $3 million grant from the Open Society Institute, PIH is taking on an epidemic that has been widely described as "incurable" and that threatens to reverse recent progress in combatting HIV/AIDS